Cynthia Jordan/learnlooklocate.com
Aug 6, 2025, 22:14
Cynthia Jordan: Treatment Options for Triple-Negative Breast Cancer
Cynthia Jordan, Founder and CEO of Learn Look Locate, shared a post on LinkedIn:
“Treatment Options for Triple-Negative Breast Cancer (TNBC)
Triple-Negative Breast Cancer doesn’t respond to hormonal or HER2-targeted therapies—making treatment decisions even more critical.
Our new medically vetted page breaks down the latest options, with expert insights from Maryam Lustberg, Medical Oncologist at Yale Cancer Center and Learn Look Locate Medical Advisor.
What’s covered:
- Chemotherapy—often first-line and highly effective
- Immunotherapy—Keytruda (pembrolizumab) for PD-L1+ tumors
- Targeted therapy—Trodelvy and PARP inhibitors for BRCA mutations
- Clinical trials and emerging research”
More posts featuring Cynthia Jordan on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 6, 2025, 22:14
Aug 6, 2025, 21:22
Aug 6, 2025, 21:07
Aug 6, 2025, 21:01
Aug 6, 2025, 20:49
Aug 6, 2025, 20:34
Aug 6, 2025, 20:03